Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Alarms and Alerts Handling During Culture – V 2.0

Posted on By


Biosimilars: SOP for Alarms and Alerts Handling During Culture – V 2.0


Standard Operating Procedure for Alarms and Alerts Handling During Culture in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/149/2025
Supersedes SOP/BS/149/2022
Page No. Page 1 of 9
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define a standardized approach for handling, investigating, and documenting alarms and alerts generated during culture operations in biosimilar upstream processing. This ensures process continuity, product quality, and GMP compliance.

2. Scope

This SOP applies to all automated bioreactor systems, incubators, culture monitoring systems, and support utilities generating audio/visual or software-based alarms during biosimilar manufacturing.

3. Responsibilities

  • Production Operators: Monitor alarms and alerts, take immediate action as per instructions, and document the event.
  • Engineering: Investigate equipment-related faults and restore functionality.
  • QA: Review alarm incidents and approve CAPA if critical deviations are involved.

4. Accountability

The Head of Manufacturing is accountable for ensuring alarm handling procedures are followed, documented, and reviewed for compliance and process robustness.

5. Procedure

5.1 Types of Alarms and Alerts

  1. Process Alarms: Deviations in setpoint parameters like temperature, pH, DO, agitation speed.
  2. Equipment Alarms: Malfunctions such as motor failure, pump stoppage, sensor disconnection.
  3. System Alerts: Communication errors, power backup switching, minor warnings not affecting critical control.

5.2 Alarm Detection and Initial Response

  1. All alarms shall trigger a visual or audible indicator and log entry in SCADA/BMS/PLC system.
  2. Operators must acknowledge the alarm within 2 minutes.
  3. Review the alarm message, timestamp, and parameter deviation details.

5.3 Immediate Actions

  1. If within alert range: monitor closely, inform supervisor, and continue process.
  2. If alarm is critical:
    • Pause process if required.
    • Isolate the affected system.
    • Initiate corrective action such as resetting the controller or switching to backup equipment.
  3. Log the alarm in Annexure-1: Alarm Handling Log and inform QA if it may impact batch quality.

5.4 Investigation and Documentation

  1. Engineering to perform system diagnostics and identify root cause.
  2. QA to initiate deviation if alarm led to parameter excursion or batch impact.
  3. Attach alarm printout and controller logs to Annexure-2: Alarm Investigation Form.

5.5 Closure and Review

  1. After resolution, reset system and resume operations as per QA approval.
  2. QA to trend alarms monthly and assess reoccurrence for system improvements.

6. Abbreviations

  • SCADA: Supervisory Control and Data Acquisition
  • QA: Quality Assurance
  • PLC: Programmable Logic Controller
  • BMS: Building Management System

7. Documents

  1. Alarm Handling Log – Annexure-1
  2. Alarm Investigation Form – Annexure-2

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • EU GMP Annex 11 – Computerized Systems
  • FDA CFR Part 211 – Subpart D: Equipment

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Alarm Handling Log

Date System Parameter Alarm Type Action Taken Operator
03/05/2025 Bioreactor-5 DO High Alarm Reduced airflow Ajay Verma

Annexure-2: Alarm Investigation Form

Alarm ID Date Description Root Cause Corrective Action QA Review
AL-DO-037 03/05/2025 DO spike > 85% Flow valve stuck open Replaced actuator Reviewed

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Expanded alarm classification and added SCADA integration steps System enhancement
See also  Biosimilars: SOP for ELISA-Based Screening of Clones - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Gel Manufacturing: SOP for Cleaning of Gel Transfer Vessels – V 2.0
Next Post: Analytical Method Development: SOP for Linearity and Range Determination – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version